Recently, KLK2 has been implicated in carcinogenesis and tumor metastasis of prostate cancer (23), whereas it is a useful serum marker of prostate cancer due to its association with prostatic proliferative disorders and tissue specificity (24, 25). This evidence concerns the gene KLK2 and prostate carcinoma.